Form 4: Immuneering Corp Director Thomas J. Schall Acquires Additional Shares

Director Thomas J. Schall of Immuneering Corp [IMRX] purchased 2,900 shares of Class A Common Stock on March 22, 2024, at an average price of $2.5465 per share.

Summary

• On March 22, 2024, Thomas J. Schall, a director of Immuneering Corp [IMRX], acquired 2,900 shares of Class A Common Stock.
• The purchase was made at a weighted average price of $2.5465 per share.
• The transactions were executed in multiple trades with prices ranging from $2.53 to $2.55.
• Following the reported transaction, Schall directly owns 2,900 shares of Immuneering Corp.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but the scale of the purchase is relatively small.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider trading activity is closely monitored as it can provide insights into a company's performance and future prospects. Purchases by insiders are generally viewed more favorably than sales.

Stakeholder Impact

• The purchase could have a minor positive impact on shareholder sentiment.

Key Dates